Martínez-López, I.; Maurino, J.; Sanmartín-Fenollera, P.; Ontañon-Nasarre, A.; Santiago-Pérez, A.; Moya-Carmona, I.; García-Collado, C.G.; Fernández-Del Olmo, R.; García-Arcelay, E.; Sarmiento, M.;
et al. Assessing Pharmacists’ Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis. Pharmacy 2020, 8, 61.
https://doi.org/10.3390/pharmacy8020061
AMA Style
Martínez-López I, Maurino J, Sanmartín-Fenollera P, Ontañon-Nasarre A, Santiago-Pérez A, Moya-Carmona I, García-Collado CG, Fernández-Del Olmo R, García-Arcelay E, Sarmiento M,
et al. Assessing Pharmacists’ Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis. Pharmacy. 2020; 8(2):61.
https://doi.org/10.3390/pharmacy8020061
Chicago/Turabian Style
Martínez-López, Iciar, Jorge Maurino, Patricia Sanmartín-Fenollera, Ana Ontañon-Nasarre, Alejandro Santiago-Pérez, Isabel Moya-Carmona, Carlos Gustavo García-Collado, Raquel Fernández-Del Olmo, Elena García-Arcelay, Mònica Sarmiento,
and et al. 2020. "Assessing Pharmacists’ Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis" Pharmacy 8, no. 2: 61.
https://doi.org/10.3390/pharmacy8020061
APA Style
Martínez-López, I., Maurino, J., Sanmartín-Fenollera, P., Ontañon-Nasarre, A., Santiago-Pérez, A., Moya-Carmona, I., García-Collado, C. G., Fernández-Del Olmo, R., García-Arcelay, E., Sarmiento, M., Carreño, Á., & Pérez-Encinas, M.
(2020). Assessing Pharmacists’ Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis. Pharmacy, 8(2), 61.
https://doi.org/10.3390/pharmacy8020061
